MoneyTreeTM venture capital funding: Biotech bounce

November 2012
  • Print-friendly version
MoneyTree<sup>TM</sup> venture capital funding: Biotech bounce

At a glance

US venture capital funding in life sciences increased in the third quarter 2012, but the sector still trended downward for the year, according to the MoneyTree™ Report from PricewaterhouseCoopers LLP (PwC) and the National Venture Capital Association (NVCA) based on data provided by Thomson Reuters.

Venture capital (VC) funding in the Life Sciences sector, which includes the Biotechnology and Medical Device industries, gained in Q3 in terms of dollars from the second quarter of 2012, but the sector still trended downward for the year according to the MoneyTreeTM Report from PricewaterhouseCoopers (PwC) LLP and the National Venture Capital Association (NVCA) based on data provided by Thomson Reuters.